By Jeannie O'Sullivan ( October 18, 2021, 2:06 PM EDT) -- Investors who poured money into heart-drug maker Amarin Corp. PLC urged the Third Circuit to revive their lawsuit accusing the company and its officials of concealing clinical trial issues that led to a stock crash, saying general warnings about hypothetical possibilities didn't suffice when actual problems arose....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.